Emcure Pharmaceuticals Limited — Folic Exporter Profile
Indian Pharmaceutical Exporter · #12 for Folic · $935.8K export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #12 Indian exporter of Folic with $935.8K in export value and 99 verified shipments. Emcure Pharmaceuticals Limited holds a 1.7% market share in Folic exports across 13 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Folic Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Folic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $339.1K | 18 | 35.4% |
| MAURITIUS | $316.9K | 39 | 33.0% |
| THAILAND | $78.2K | 12 | 8.1% |
| SRI LANKA | $44.6K | 4 | 4.6% |
| VIETNAM | $40.3K | 2 | 4.2% |
| VIETNAM, DEMOCRATIC REP. OF | $25.0K | 2 | 2.6% |
| PHILIPPINES | $20.6K | 2 | 2.2% |
| TRINIDAD & TOBAGO | $20.0K | 2 | 2.1% |
| KYRGHYSTAN | $19.5K | 4 | 2.0% |
| ZIMBABWE | $14.6K | 4 | 1.5% |
Emcure Pharmaceuticals Limited exports Folic to 16 countries. The largest destination is MYANMAR accounting for 35.4% of Emcure Pharmaceuticals Limited's Folic shipments, followed by MAURITIUS (33.0%) and THAILAND (8.1%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Folic from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| KHETAN COMPANY LIMITED | MYANMAR | $339.1K | 18 |
| THE MAURITIUS PHARMACY(SEEGOBIN)LTD | MAURITIUS | $108.5K | 10 |
| THE MAURITIUS PHARMACY SEEGOBIN | MAURITIUS | $105.9K | 10 |
| ALLIANCE PHARMA CO., LTD. | THAILAND | $52.7K | 8 |
| THE MAURITIUS PHARMACY (SEEGOBIN) | MAURITIUS | $42.8K | 10 |
| VIETNAM MEDICAL PRODUCTS IMPORT | VIETNAM | $40.3K | 2 |
| THE MAURITIUS PHARMACY SEEGOBIN LTD | MAURITIUS | $34.0K | 2 |
| EMERCHEMIE NB (CEYLON) LIMITED | SRI LANKA | $26.9K | 2 |
| VIETNAM MEDICAL PRODUCTS | VIETNAM, DEMOCRATIC REP. OF | $25.0K | 2 |
| SCOTT HEALTH LTD | MAURITIUS | $20.0K | 3 |
Emcure Pharmaceuticals Limited supplies Folic to 28 buyers globally. The largest buyer is KHETAN COMPANY LIMITED (MYANMAR), followed by THE MAURITIUS PHARMACY(SEEGOBIN)LTD (MAURITIUS) and THE MAURITIUS PHARMACY SEEGOBIN (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Folic Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $22.4M worth of Folic through 5,361 shipments from 693 suppliers to 148 countries, serving 1,433 buyers globally. Emcure Pharmaceuticals Limited contributes $935.8K to this total, accounting for 1.7% of India's Folic exports. Emcure Pharmaceuticals Limited ships Folic to 16 countries through 28 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Folic Exports?
Emcure Pharmaceuticals Limited's average Folic shipment value is $9.5K per consignment, based on 99 shipments totaling $935.8K. The largest destination is MYANMAR (35.4% of Emcure Pharmaceuticals Limited's Folic exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Folic Exporters?
Emcure Pharmaceuticals Limited ranks #12 among 693 Indian Folic exporters with a 1.7% market share. The top 3 exporters are GRACURE PHARMACEUTICALS LIMITED ($3.0M), STRIDES PHARMA SCIENCE LIMITED ($2.8M), CADILA PHARMACEUTICALS LIMITED ($2.6M). Emcure Pharmaceuticals Limited processed 99 shipments to 13 destination countries.
What Folic Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS PRODUCTS FINISHED PRODUCT FERIUM XT 100 1 5 MG TABLET 1X10 FERROUS ASCORBATE FOLIC ACID TABLET | $196.5K | 5 |
| ZEMCIFER XT 100/1.5 MG TABLET 3X10(FERROUS ASCORBATE&FOLIC ACID TABS. 100MG/1.5MG)B/NO.E16VS24001 M/D.4/2024 E/D.3.2026 | $50.0K | 2 |
| OROFER 100 MG/550 MCG CAP.5X2X10(IRON(III)HYDROXIDE POLY.COMPLEX &FOLIC ACID CAP.100MG/550MCG)B#E16SN23035 TO E16SN23037 | $50.0K | 1 |
| FERIUM XT 100/1.5 MG TABLET 1X10FERROUSASCORBATE & FOLIC ACID TABLETS 100MG/1.5MGBAT.NO.E16RF23001E16RF23002 | $40.3K | 1 |
| ZEMCIFER XT 100/1.5 MG TABLET 3X10 FERROUS ASCORBATE & FOLIC ACID TABLETS 100MG/1.5MG BAT.NO. E16VS23002 DOM:09/2023 | $37.4K | 2 |
| ZEMCIFER XT 100/1.5MG TABLET 3X10(FERROUS ASCORBATE & FOLIC ACID TABS 100MG/1.5MG)B#E16VS25001 MFG.20.03.25 EXP.28.02.27 | $34.7K | 1 |
| ZEMCIFER XT 100 1 5MG TABLET 3X10 FERROUS ASCORBATE FOLIC ACID TABS 100MG 1 5MG B E16VS25001 MFG 20 03 25 EXP 28 02 27 | $34.0K | 1 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM - FINISHED PRODUCT FERIUM XT 100/1.5 MG TABLET 1X10 FERROUS ASCORBATE & FOLIC ACID TABLETS | $33.4K | 1 |
| PHARMACEUTICALS PRODUCTS -(FINIS. PRODUCT) FERIUM XT 100/1.5 MG TABLET 1X10 ( FERROUS ASCORBATE & FOLIC ACID TABLETS 100 | $31.3K | 1 |
| OROFER 100MG/550MCG CAPSULES 2X20IRONIIIHYDROXIDE POLYMALTOSE COMPLEX & FOLIC ACID CAPSULES 100MG/550MCG9000PACKS | $30.0K | 1 |
Emcure Pharmaceuticals Limited exports 70 distinct Folic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS PRODUCTS FINISHED PRODUCT FERIUM XT 100 1 5 with 5 shipments worth $196.5K.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Folic Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | UMAVIDA PHARMA PRIVATE LIMITED | $1.1M | 23 | 1 | $50.0K |
| 11 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED | $1.0M | 23 | 5 | $45.5K |
| 12 | EMCURE PHARMACEUTICALS LIMITED ★ | $935.8K | 99 | 13 | $9.5K |
| 7 | BIOPLUS LIFE SCIENCES PRIVATE LIMITED | $850.0K | 17 | 11 | $50.0K |
| 13 | WOCKHARDT LIMITED | $800.0K | 16 | 1 | $50.0K |
Emcure Pharmaceuticals Limited ranks #12 among 693 Indian Folic exporters. Average shipment value of $9.5K compared to the market average of $32.3K. The closest competitors by value are UMAVIDA PHARMA PRIVATE LIMITED and SIDHAANT LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Folic Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 679 | 12.7% |
| JNPT | 390 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 348 | 6.5% |
| SAHAR AIR | 334 | 6.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 284 | 5.3% |
| MUNDRA SEA | 184 | 3.4% |
| DELHI AIR | 158 | 2.9% |
| PATLI ICD | 153 | 2.9% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Folic Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Folic, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Folic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Folic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 105 individual customs records matching Emcure Pharmaceuticals Limited exporting Folic, covering 70 formulations to 16 countries via 28 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 1,433+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Folic Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Folic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Folic Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Folic. For current shipment-level data, contact TransData Nexus.